Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Scandinavian Biopharma Holding AB
AB
Active
Org 5567872469
Industrivägen 1, 171 48
Solna
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2009
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Scandinavian Biopharma Holding AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
30M
59M
89M
118M
27M
2020
31M
2021
39M
2022
68M
2023
103M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
-1M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
26 683
30 822
39 051
67 516
102 663
Staff expenses
—
—
—
—
—
EBITDA
373
465
326
−506
−200
Depreciation & amort.
−353
−431
−472
−442
−381
EBIT
20
34
−146
−948
−581
Net financials
−7
−5
182
1 035
659
Profit before tax
13
28
37
86
78
Tax
−9
−11
−18
−35
−47
Net profit
4
17
19
51
31
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
105 123
100 240
98 121
105 811
95 323
Equity
12 958
14 405
15 674
13 068
13 599
Long-term debt
0
0
0
0
0
Short-term debt
92 165
85 835
82 447
92 742
81 724
Total debt
92 165
85 835
82 447
92 742
81 724
Financial ratios
5-year trend
EBITDA margin
-0.2%
This company
15.8%
Market median
-101% vs market
2020
2024
Equity ratio
14.3%
This company
38.2%
Market median
-63% vs market
2020
2024
Return on equity
0.2%
This company
18.4%
Market median
-99% vs market
2020
2024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2020
2024
Asset turnover
1.08×
This company
1.12×
Market median
+4% vs market
2020
2024
Debt / equity
6.01×
This company
0.62×
Market median
-869% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Scandinavian Biopharma Holding AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
